• Psychedelic Medicine Is the Next Investment Megatrend

    Legacy Research Group

    November 24, 2020

    Chris’ note: 403% in just over eight months… That's how much one tiny psychedelic medicine stock is up since colleague Nick Giambruno recommended it to readers of our Crisis Investing advisory.

    As you’ll hear from Nick below, psychedelic medicine is far from something to do with hippies and dropouts. It’s helping America’s war heroes get over PTSD without the usual cocktail of pharmaceutical drugs.

    Now, don’t me wrong. This is as fringe an investment idea as you’re going to find. It’s on only the savviest investors’ radars. But as Nick reveals below… we’re only at the start of this new market megatrend.


    Psychedelic Medicine Is the Next Investment Megatrend

    By Nick Giambruno, Chief Analyst, Crisis Investing

    Jeff Brown

    Suicide has killed more U.S. soldiers than actual combat in Iraq, Afghanistan, and Vietnam… combined.

    Every day, 22 veterans commit suicide.

    It’s a tragedy that’s hard for a lot of people to understand.

    Unlike physical wounds, which generally heal over time, psychological and spiritual wounds don’t necessarily go away.

    Of the over 2.7 million soldiers who served in Iraq and Afghanistan, around 20% have been diagnosed with post-traumatic stress disorder (PTSD). That’s more than 540,000 people.

    There’s a lot of confusion about PTSD. Part of the reason is in the term itself. It’s sterile, nondescriptive, and detached from humanity.

    Here is how George Carlin described it. Though he was a legendary comedian, his take on this deadly serious topic is still spot-on.

    I don’t like words that hide the truth. I don’t like words that conceal reality. I don’t like euphemisms or euphemistic language, and American English is loaded with euphemisms ’cause Americans have a lot of trouble dealing with reality.

    Americans have trouble facing the truth. So they invent the kind of a soft language to protect themselves from it. And it gets worse with every generation. For some reason, it just keeps getting worse.

    I’ll give you an example of that. There’s a condition in combat. Most people know about it. It’s when a fighting person’s nervous system has been stressed to its absolute peak and maximum – can’t take any more input. The nervous system has either snapped or is about to snap.

    In the first World War, that condition was called shell shock. Simple, honest, direct language. Two syllables. Shell shock. Almost sounds like the guns themselves.

    Then a whole generation went by, and the second World War came along. And the very same combat condition was called battle fatigue. Four syllables now. Takes a little longer to say, doesn’t seem to hurt as much. Fatigue is a nicer word than shock, shell shock. Battle fatigue.

    Then we had the war in Korea in 1950. Madison Avenue was riding high by that time. And the very same combat condition was called operational exhaustion. Hey, we’re up to eight syllables now. And the humanity has been squeezed completely out of the phrase. It’s totally sterile now. Operational exhaustion. Sounds like something that might happen to your car.

    Then, of course, came the war in Vietnam… And thanks to the lies and deceit surrounding that war, I guess it’s no surprise that the very same condition was called post-traumatic stress disorder. Still eight syllables, but we’ve added a hyphen. And the pain is completely buried under jargon. Post-traumatic stress disorder.

    I’ll bet you if we’d have still been calling it shell shock, some of those Vietnam veterans might’ve gotten the attention they needed at the time.

    When doctors diagnose a veteran with PTSD, it’s common for them to prescribe a cocktail of dangerous pharmaceuticals.

    One veteran recalled taking over 90 different prescription drugs.

    For many, not only are the prescription drugs ineffective, but they introduce even more problems.

    Desperate to find anything that could help, a growing number of veterans have turned to unconventional – and in some cases illegal – treatments…

    Unconscionable Situation

    Many veterans have found lifesaving relief from illegal psychedelic drugs.

    Growing evidence suggests psychedelics can help treat depression, anxiety, addiction, and PTSD, potentially stemming the tide of suicides among vets.

    Psychedelics are a class of drugs whose primary action is to trigger thought, visual, and auditory changes, and an altered state of consciousness. Major psychedelic drugs include mescaline, LSD, psilocybin (magic mushrooms), and DMT.

    Humans have used these mind-altering substances for thousands of years.

    But the federal government classifies most psychedelics as Schedule I drugs, its most severe category, which means it believes they have “a high potential for abuse and no accepted medical use.” It’s a patently absurd situation.

    It’s terrible enough for the politicians in Washington, D.C., to send young people into these ridiculous endless wars. But it’s truly beyond unconscionable to threaten veterans with arrest and imprisonment when they return with PTSD and seek lifesaving medicine.

    Thankfully, the situation is changing rapidly. The legalization of psychedelic-based medicine is coming soon. It’s going to save countless lives.

    It’s also going to create a new industry with enormous profit potential for investors.

    Are You Collecting "Tech Royalty" Income?

    This Is on Only the Savviest Investors’ Radars

    It’s a rare opportunity to get in on the ground floor of an industry that’s positively changing the world.

    You may not be aware, but psychedelic legalization has taken a big step forward in the U.S. in recent months.

    Today, investing in psychedelics is on only the savviest investors’ radars.

    Tim Ferriss is a bestselling author and entrepreneur. He’s also a renowned angel investor who made well-timed bets on Uber (UBER), Twitter (TWTR), Alibaba (BABA), Shopify (SHOP), Duolingo, Facebook (FB), and many others.

    He recently said this about investing in psychedelics:

    I view the next five years as an absolutely golden window. There’s an opportunity to use relatively small amounts of money to have billions of dollars of impact and to affect millions of lives. There just aren’t that many opportunities that are so dramatically obvious.

    Billionaires like Peter Thiel, the founder of PayPal (PYPL), and Mike Novogratz are also getting involved. So are Steve Cohen, a hedge fund manager and the owner of the New York Mets, and Bob Parsons, the founder of GoDaddy (GDDY).

    The first psychedelic medicine company went public on a major U.S. stock exchange at the end of September. It’s share price skyrocketed over 70% on its first day of trading.

    The momentum is building. It won’t be long before psychedelics go mainstream, even if that seems unbelievable right now.

    The medicinal and profit potential is too big to ignore.

    Flesh of the Gods

    Psilocybin, or magic mushrooms, is leading the way in psychedelic legalization.

    Some historians believe art and other archeological artifacts show that humans may have used psilocybin as far back as 9000 B.C.

    The Aztecs used a substance called teonanácatl, which means “flesh of the gods.” Many believe it was magic mushrooms.

    Today, more than 100 species of mushrooms worldwide produce psilocybin.

    Scientists don’t entirely understand how psilocybin affects the brain. It seems to work by binding to serotonin receptors. Psilocybin also appears to help connect networks in the brain, leading to a higher state of consciousness and complex emotions.

    According to Matthew Johnson, a professor at Johns Hopkins University, with psilocybin:

    There’s no dose with observable organ damage or neurotoxicity. You’d be hard-pressed to find anything sold over the counter that you could say this about – including caffeine and aspirin.

    Mushroom Millionaires and the Next Investment Frontier

    The U.S. government, and most others around the world, have long banned psilocybin. However, significant cracks in the prohibition regime have appeared – and are growing wider.

    As was the case with cannabis, proving psilocybin has medicinal benefits has been a big step towards ending prohibition.

    In 2012, Colorado made history by becoming the first state (along with Washington) to legalize recreational cannabis. Now, 36 states have already legalized cannabis in some form.

    In 2019, Colorado made history again when Denver became the first U.S. jurisdiction to decriminalize magic mushrooms.

    Colorado was a bellwether for cannabis, and it will be for psilocybin as well.

    Oakland and Santa Cruz, California, have decriminalized not only magic mushrooms, but ayahuasca and mescaline, too.

    Ann Arbor, Michigan, has decriminalized several psychedelics.

    Today, there are efforts to legalize psychedelics in about 100 other U.S. cities.

    Washington, D.C., voted to decriminalize psychedelics in the election earlier this month.

    The state of Oregon also voted to legalize psilocybin for therapeutic purposes, becoming the first U.S. state to legalize psychedelic mushrooms.

    Canada has also softened its psilocybin restrictions. In September, Canada legalized its use for certain cancer patients.

    The situation with psilocybin is reminiscent of cannabis around 2012, right around when the first states started legalizing recreational use. It gave birth to a global megatrend worth hundreds of billions of dollars and created fortunes for early investors.

    I think we’re going to see the same thing happen with psilocybin. But it could happen much faster, as cannabis has already blazed the legalization trail.

    Cannabis provided a legalization template for other substances, and psilocybin is next.

    That’s why investing in psilocybin today is like investing in cannabis at the beginning of the legalization trend.

    I just recommended an exciting company at the forefront of the magic mushroom trend in my latest issue of Crisis Investing. For all the details on that, along with how to access all my top picks to profit off the growing legalization of psychedelics and cannabis, go here.

    Regards,

    signature

    Nick Giambruno
    Chief Analyst, Crisis Investing

    Like what you’re reading? Send your thoughts to feedback@legacyresearch.com.

    IN CASE YOU MISSED IT…

    NOW PLAYING Special "Catch-Up" Event With Big T

    Is it possible to catch up on all the crypto gains you may have missed out on?

    YES!

    In a new presentation, crypto expert Teeka Tiwari is revealing:

    • An accidental discovery he just stumbled upon…

    • Why it’s giving you one last chance to get the life you’ve always wanted… 

    • And the name of his top pick – FREE.

    Watch now.

    image


    Get Instant Access

    Click to read these free reports and automatically sign up for daily research.

    image

    The Gold Investor’s Guide

    image

    An Insider’s Guide to Making a Fortune from Small Tech Stocks

    image

    How to Make A Fortune From Legal Cannabis

    Share FACEBOOK
    Tweet TWITTER

    To ensure our emails continue reaching your inbox, please add our email address to your address book.

    This editorial email containing advertisements was sent to jamgdi.newtrendingoffers@blogger.com because you subscribed to this service. To stop receiving these emails, click here.

    Legacy Research Group welcomes your feedback and questions. But please note: The law prohibits us from giving personalized advice.

    To contact Customer Service, call toll free Domestic/International: 1-888-413-5232, Mon–Fri, 9am–5pm ET, or email us here. 55 NE 5th Avenue, Delray Beach, FL 33483.

    © 2020 Legacy Research Group, LLC. All rights reserved. Any reproduction, copying, or redistribution of our content, in whole or in part, is prohibited without written permission from Legacy Research Group, LLC.

    Privacy Policy | Terms of Use

  • 0 comments:

    Post a Comment